Achieving net-zero medicine through supply chain innovation

Despite the carbon footprint from packaging pills to active pharmaceutical ingredient (API) development, Aleiya Lonsdale, head of Event, Lab Innovations, explains how pharma companies in the UK can do their part to help achieve net zero by 2040.